by Yingchun Ni | Nov 15, 2017 | Commentary |
On February 15, 2017, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued a ruling on a patent dispute about a genome-editing technique called CRISPR-Cas9. The Regents of the University of California, University of...
